Comparative Pharmacology
Head-to-head clinical analysis: DEXTROSE 4 IN MODIFIED LACTATED RINGER S IN PLASTIC CONTAINER versus DEXTROSE 5 AND LACTATED RINGER S IN PLASTIC CONTAINER.
Head-to-head clinical analysis: DEXTROSE 4 IN MODIFIED LACTATED RINGER S IN PLASTIC CONTAINER versus DEXTROSE 5 AND LACTATED RINGER S IN PLASTIC CONTAINER.
DEXTROSE 4% IN MODIFIED LACTATED RINGER'S IN PLASTIC CONTAINER vs DEXTROSE 5% AND LACTATED RINGER'S IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dextrose provides glucose for cellular energy metabolism. Lactated Ringer's solution replaces extracellular fluid and electrolytes. Lactate is metabolized to bicarbonate in the liver, providing buffering capacity for metabolic acidosis.
Dextrose provides a source of carbohydrates for metabolism, while Lactated Ringer's solution replaces extracellular fluid and electrolytes. Lactate is converted to bicarbonate in the liver, providing buffer.
Intravenous infusion; adult dose is 500-1000 mL per 24 hours, titrated to fluid and electrolyte needs.
Intravenous infusion, dose depends on fluid and caloric needs; typical adult dose is 30-40 mL/kg/day, not to exceed 100 mL/hour in normovolemic patients without cardiac impairment.
None Documented
None Documented
2–4 hours (intravenous). Clinical context: reflects glucose clearance; prolonged in renal impairment.
Dextrose: 1-2 hours (intracellular utilization); lactate: 10-20 minutes (hepatic metabolism); water and electrolytes: distribution half-life ~20-30 minutes, elimination half-life determined by renal function (normal ~2-4 hours).
Renal: >99% as glucose. Biliary/fecal: negligible (<1%).
Lactate is metabolized to bicarbonate in the liver (80%) and kidneys (20%); dextrose is metabolized to CO2 and water via glycolysis and the Krebs cycle; water is excreted renally (100%), electrolytes (Na+, K+, Ca2+, Cl-) are primarily renally eliminated with minimal fecal loss (<2%).
Category C
Category C
IV Fluid
IV Fluid